| Document Date: 2012-05-31 05:55:35
Open Document File Size: 1,15 MBShare Result on Facebook
City Ishikawa / Omaha / PWR / / Company Nikon / Roche Diagnostics GmbH / Visual Sciences / Macmillan Publishers Limited / / Country United States / / / Event Product Issues / / Facility University of Nebraska Medical Center / terminal LEDGF / University of Kanazawa / / / IndustryTerm image analyzer software / interference technology / cancer treatment / / MedicalCondition human prostate carcinomas / BPH / prostate carcinogenesis / tumorigenicity/ metastasis / metastasis / different prostate adenocarcinoma cell lines / prostate cancer / prostate cancer DU145 / cancers / tumor / cancer / Disease / DU145 cancer / carcinogenesis / inflammatory conditions / Cancer A / prostate tumors / inflammation / human prostate carcinoma / prostate carcinoma / / Organization Nebraska Medical Center / Department of Ophthalmology and Visual Sciences / University of Kanazawa / University of Nebraska / / / Position Japan *Corresponding author / Major / Representative / reporter / / Product B47 / cell cycle / cells / / ProvinceOrState Nebraska / South Dakota / / Technology siRNA / antibodies / apoptosis / CAT / 2 transcription-based therapeutics.30 The RNA interference technology / / URL www.nature.com/cddis / /
SocialTag |
Citation: Cell Death and Disease[removed], e316; doi:[removed]cddis[removed] & 2012 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis LEDGF gene silencing impairs the tumorigenicity of